These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1404 related items for PubMed ID: 21851896

  • 1. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
    Brilakis ES, Rao SV, Banerjee S, Goldman S, Shunk KA, Holmes DR, Honeycutt E, Roe MT.
    JACC Cardiovasc Interv; 2011 Aug; 4(8):844-50. PubMed ID: 21851896
    [Abstract] [Full Text] [Related]

  • 2. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
    Brilakis ES, Wang TY, Rao SV, Banerjee S, Goldman S, Shunk K, Kar B, Holmes DR, Dai D, Chin CT, Harding TM, Roe MT.
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Brilakis ES, O'Donnell CI, Penny W, Armstrong EJ, Tsai T, Maddox TM, Plomondon ME, Banerjee S, Rao SV, Garcia S, Nallamothu B, Shunk KA, Mavromatis K, Grunwald GK, Bhatt DL.
    JACC Cardiovasc Interv; 2016 May 09; 9(9):884-93. PubMed ID: 27085582
    [Abstract] [Full Text] [Related]

  • 4. Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.
    Varghese I, Samuel J, Banerjee S, Brilakis ES.
    Cardiovasc Revasc Med; 2009 May 09; 10(2):103-9. PubMed ID: 19327672
    [Abstract] [Full Text] [Related]

  • 5. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
    Frutkin AD, Lindsey JB, Mehta SK, House JA, Spertus JA, Cohen DJ, Rumsfeld JS, Marso SP, NCDR (National Cardiovascular Data Registry).
    JACC Cardiovasc Interv; 2009 Jul 09; 2(7):614-21. PubMed ID: 19628183
    [Abstract] [Full Text] [Related]

  • 6. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
    Yap CH, Yan BP, Akowuah E, Dinh DT, Smith JA, Shardey GC, Tatoulis J, Skillington PD, Newcomb A, Mohajeri M, Pick A, Seevanayagam S, Reid CM.
    JACC Cardiovasc Interv; 2009 Aug 09; 2(8):758-64. PubMed ID: 19695544
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.
    Gaglia MA, Torguson R, Xue Z, Gonzalez MA, Ben-Dor I, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.
    Catheter Cardiovasc Interv; 2011 Jul 01; 78(1):23-9. PubMed ID: 21061247
    [Abstract] [Full Text] [Related]

  • 8. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES, Lasala JM, Cox DA, Berger PB, Bowman TS, Starzyk RM, Dawkins KD.
    JACC Cardiovasc Interv; 2010 Jul 01; 3(7):742-50. PubMed ID: 20650436
    [Abstract] [Full Text] [Related]

  • 9. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ, Holmes DR, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP, SYNTAX Investigators.
    JACC Cardiovasc Interv; 2012 Jun 01; 5(6):618-25. PubMed ID: 22721656
    [Abstract] [Full Text] [Related]

  • 10. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF, EVENT Investigators.
    Catheter Cardiovasc Interv; 2012 Dec 01; 80(7):1127-36. PubMed ID: 22431166
    [Abstract] [Full Text] [Related]

  • 11. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR, Wilson H, Stuckey T, Nussbaum M, Laurent S, Bradshaw B, Humphrey A, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA, STENT Group.
    JACC Cardiovasc Interv; 2009 Nov 01; 2(11):1105-12. PubMed ID: 19926052
    [Abstract] [Full Text] [Related]

  • 12. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR, O'Neill WW, Hamm CW, Van de Werf F, Armstrong PW, APEX AMI Investigators.
    JACC Cardiovasc Interv; 2010 Mar 01; 3(3):343-51. PubMed ID: 20298996
    [Abstract] [Full Text] [Related]

  • 13. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ, Head SJ, Holmes DR, Ståhle E, Feldman TE, Colombo A, Morice MC, Unger F, Erglis A, Stoler R, Dawkins KD, Serruys PW, Mohr FW, Kappetein AP.
    JACC Cardiovasc Interv; 2013 Apr 01; 6(4):344-54. PubMed ID: 23523456
    [Abstract] [Full Text] [Related]

  • 14. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
    JACC Cardiovasc Interv; 2014 Apr 01; 7(4):354-61. PubMed ID: 24630886
    [Abstract] [Full Text] [Related]

  • 15. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
    JACC Cardiovasc Interv; 2013 Dec 01; 6(12):1242-9. PubMed ID: 24355114
    [Abstract] [Full Text] [Related]

  • 16. Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting.
    Xanthopoulou I, Davlouros P, Tsigkas G, Panagiotou A, Hahalis G, Alexopoulos D.
    Can J Cardiol; 2011 Dec 01; 27(6):716-24. PubMed ID: 22019279
    [Abstract] [Full Text] [Related]

  • 17. Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG.
    Mavroudis CA, Kotecha T, Chehab O, Hudson J, Rakhit RD.
    Int J Cardiol; 2017 Feb 01; 228():563-569. PubMed ID: 27875735
    [Abstract] [Full Text] [Related]

  • 18. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW, Goldberg S, O'Shaughnessy C, Midei M, Siegel RM, Cristea E, Dangas G, Lansky AJ, Mehran R.
    JACC Cardiovasc Interv; 2011 Mar 01; 4(3):300-9. PubMed ID: 21435608
    [Abstract] [Full Text] [Related]

  • 19. [Correlation between previous coronary artery stenting and early mortality in patients undergoing coronary artery bypass graft surgery].
    Ghodbane W, Ragmoun W, Arbi R, Brahem W, Sahraoui C, Lejmi M, Taamallah K, Massoudi H, Lebbi A, Ziadi M, Lahdhili H, Bey M, Chenik S.
    Ann Cardiol Angeiol (Paris); 2013 Dec 01; 62(6):429-34. PubMed ID: 23582999
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP, Clark DJ, Buxton B, Ajani AE, Smith JA, Duffy SJ, Shardey GC, Skillington PD, Farouque O, Yii M, Yap CH, Andrianopoulos N, Brennan A, Dinh D, Reid CM, Australasian Society of Cardiac and Thoracic Surgeons (ASCTS), Melbourne Interventional Group (MIG).
    Heart Lung Circ; 2009 Jun 01; 18(3):184-90. PubMed ID: 19268632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.